Nuntius Therapeutics

Nuntius Therapeutics develops transformative mRNA therapies by leveraging proprietary delivery technology, machine learning and superior nucleic acid engineering. The company focuses on genetic medicines to cure patients with life-threatening diseases including cancer, lung diseases and neurodegenerative diseases. Their programmable, scalable, and non-immunogenic nanocarriers can target tissues and cell types beyond the liver.